109 related articles for article (PubMed ID: 10670411)
21. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of morphine-induced in vivo release of cholecystokinin in rat dorsal horn: effects of ion channel blockers.
Gustafsson H; Afrah A; Brodin E; Stiller CO
J Neurochem; 1999 Sep; 73(3):1145-54. PubMed ID: 10461906
[TBL] [Abstract][Full Text] [Related]
23. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
[TBL] [Abstract][Full Text] [Related]
24. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
Funada M; Schutz CG; Shippenberg TS
Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160
[TBL] [Abstract][Full Text] [Related]
25. Stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat: prevention by diazepam but not ondansetron.
Nevo I; Becker C; Hamon M; Benoliel JJ
J Neurochem; 1996 May; 66(5):2041-9. PubMed ID: 8780034
[TBL] [Abstract][Full Text] [Related]
26. Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse.
Billa SK; Xia Y; Morón JA
Eur J Neurosci; 2010 Aug; 32(4):625-31. PubMed ID: 20626460
[TBL] [Abstract][Full Text] [Related]
27. Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices.
Suarez-Roca H; Maixner W
Eur J Pharmacol; 1992 Dec; 229(1):1-7. PubMed ID: 1282103
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
[TBL] [Abstract][Full Text] [Related]
29. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
30. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
Stoller DC; Sim-Selley LJ; Smith FL
Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
[TBL] [Abstract][Full Text] [Related]
31. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
[TBL] [Abstract][Full Text] [Related]
32. Effects of opioid antagonists on unconditioned and conditioned hyperactivity to morphine.
Rauhut AS; Gehrke BJ; Phillips SB; Bardo MT
Pharmacol Biochem Behav; 2002 Oct; 73(3):611-22. PubMed ID: 12151036
[TBL] [Abstract][Full Text] [Related]
33. Enhanced cortical extracellular levels of cholecystokinin-like material in a model of anticipation of social defeat in the rat.
Becker C; Thièbot MH; Touitou Y; Hamon M; Cesselin F; Benoliel JJ
J Neurosci; 2001 Jan; 21(1):262-9. PubMed ID: 11150343
[TBL] [Abstract][Full Text] [Related]
34. Intramuscular administration of morphine reduces mustard-oil-induced craniofacial-muscle pain behavior in lightly anesthetized rats.
Han SR; Lee MK; Lim KH; Yang GY; Jeon HJ; Ju JS; Yoon YW; Kim SK; Ahn DK
Eur J Pain; 2008 Apr; 12(3):361-70. PubMed ID: 17768078
[TBL] [Abstract][Full Text] [Related]
35. Effects of the altered activity of δ-opioid receptor on the expression of glutamate transporter type 3 induced by chronic exposure to morphine.
Wu Q; Xia S; Lin J; Cao D; Chen W; Liu L; Fu Y; Liang J; Cao M
J Neurol Sci; 2013 Dec; 335(1-2):174-81. PubMed ID: 24120272
[TBL] [Abstract][Full Text] [Related]
36. Differential release of cholecystokinin by morphine in rat spinal cord.
de Araujo Lucas G; Alster P; Brodin E; Wiesenfeld-Hallin Z
Neurosci Lett; 1998 Mar; 245(1):13-6. PubMed ID: 9596344
[TBL] [Abstract][Full Text] [Related]
37. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions.
Lim YJ; Zheng S; Zuo Z
Anesthesiology; 2004 Mar; 100(3):562-8. PubMed ID: 15108969
[TBL] [Abstract][Full Text] [Related]
38. In vivo neurochemical evidence that delta1-, delta2- and mu2-opioid receptors, but not mu1-opioid receptors, inhibit acetylcholine efflux in the nucleus accumbens of freely moving rats.
Kiguchi Y; Aono Y; Watanabe Y; Yamamoto-Nemoto S; Shimizu K; Shimizu T; Kosuge Y; Waddington JL; Ishige K; Ito Y; Saigusa T
Eur J Pharmacol; 2016 Oct; 789():402-410. PubMed ID: 27445235
[TBL] [Abstract][Full Text] [Related]
39. Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment.
Pohl M; Collin E; Benoliel JJ; Bourgoin S; Cesselin F; Hamon M
Neuropeptides; 1992 Mar; 21(3):193-200. PubMed ID: 1630603
[TBL] [Abstract][Full Text] [Related]
40. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway.
García-Fuster MJ; Miralles A; García-Sevilla JA
Neuropsychopharmacology; 2007 Feb; 32(2):399-411. PubMed ID: 16482086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
